Dosage form for treating cardiovascular diseases
First Claim
Patent Images
1. A composition for use in an osmotic device, said composition comprising about 2 weight percent to 30 weight percent of isradipine, a polyethylene oxide comprising a molecular weight of about 200,000 to about 300,000 and a hydroxypropylemthylecellulose comprising a number average molecular weight of about 9,000 to 15,000.
2 Assignments
0 Petitions
Accused Products
Abstract
An osmotic device is disclosed comprising a first composition, and a second composition with the beneficial drug isradipine in the first composition.
-
Citations
1 Claim
-
1. A composition for use in an osmotic device, said composition comprising about 2 weight percent to 30 weight percent of isradipine, a polyethylene oxide comprising a molecular weight of about 200,000 to about 300,000 and a hydroxypropylemthylecellulose comprising a number average molecular weight of about 9,000 to 15,000.
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeALZA Corporation (Johnson & Johnson)
-
Original AssigneeALZA Corporation (Johnson & Johnson)
-
InventorsAyer, Atul D., Kuczynski, Anthony L., Swanson, David R.
-
Primary Examiner(s)Page, Thurman K.
-
Assistant Examiner(s)Howe, Leon R.
-
Application NumberUS07/267,904Time in Patent Office652 DaysField of Search424/78, 424/473, 424/468US Class Current424/473CPC Class CodesA61K 31/44 Non condensed pyridines; Hy...A61K 9/0004 Osmotic delivery systems; S...
